{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:52:41Z","timestamp":1760100761136},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Indian Council of Medical Research (ICMR), New Delhi"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.actatropica.2015.06.024","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T15:09:08Z","timestamp":1435244948000},"page":"35-41","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"150","author":[{"given":"Rahul","family":"Shivahare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preeti","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Natu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2015.06.024_bib0005","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"Alvar","year":"2006","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0015","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/1744666X.2014.942289","article-title":"An update on leptin as immunomodulator","volume":"10","author":"Conde","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0020","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.mehy.2011.05.032","article-title":"Role of leptin in human visceral leishmaniasis","volume":"77","author":"Dayakar","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exppara.2006.12.004","article-title":"Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod","volume":"116","author":"El-On","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0040","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis","volume":"24","author":"Garg","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0001-706X(02)00180-8","article-title":"Anilino-(2-bromophenyl) acetonitrile: a promising orally effective antileishmanial agent","volume":"84","author":"Gupta","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fasebj.12.1.57","article-title":"Leptin regulates proinflammatory immune responses","volume":"12","author":"Loffreda","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0060","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/cimm.1999.1594","article-title":"Human leptin enhances activation and proliferation of human circulating T lymphocytes","volume":"199","author":"Martin-Romero","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1471-4906(02)02188-9","article-title":"Balancing susceptibility to infection and autoimmunity: a role for leptin","volume":"23","author":"Matarese","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0075","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/IAI.71.11.6453-6462.2003","article-title":"Modulation of T-cell costimulation as immunotherapy or immunochemotherapy in experimental visceral leishmaniasis","volume":"71","author":"Murray","year":"2003","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0080","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QCO.0b013e32833fca9d","article-title":"Drug combinations for visceral leishmaniasis","volume":"23","author":"Olliaro","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1745-6215-12-166","article-title":"Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial","volume":"12","author":"Omollo","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0100","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","article-title":"CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis","volume":"65","author":"Sane","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.exppara.2012.05.007","article-title":"Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental visceral leishmaniasis","volume":"131","author":"Shakya","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0115","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1189\/jlb.0903415","article-title":"Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide","volume":"75","author":"Sharma","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0120","doi-asserted-by":"crossref","first-page":"e94596","DOI":"10.1371\/journal.pone.0094596","article-title":"Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis","volume":"9","author":"Shivahare","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2015.06.024_bib0125","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/jm401893j","article-title":"Synthesis, structure\u2013activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents","volume":"57","author":"Shivahare","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0135","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int.. J Infect. Dis."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0140","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/AAC.01315-13","article-title":"Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis","volume":"58","author":"Trinconi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.06.024_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0009-8981(03)00086-X","article-title":"Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes","volume":"331","author":"Walrand","year":"2003","journal-title":"Clin. Chim. Acta"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15300450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15300450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T14:35:18Z","timestamp":1566916518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X15300450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":29,"alternative-id":["S0001706X15300450"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.06.024","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}